Stock data
AngioDynamics, Inc. (ANGO)
AngioDynamics, Inc. (ANGO) reported revenue of US$320.17M and net income of -US$36.74M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-05-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | US$320.17M | US$174.89M | -US$39.93M | -US$36.74M | — |
| 2025 | US$292.50M | US$157.71M | -US$39.95M | -US$33.99M | — |
| 2024 | US$303.91M | US$154.70M | -US$192.44M | -US$184.35M | — |
| 2023 | US$338.75M | US$174.25M | -US$51.18M | -US$52.44M | — |
| 2022 | US$316.22M | US$165.73M | -US$28.47M | -US$26.55M | — |
Quarterly results
Data as of 2026-08-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-08-31 | US$80.92M | -US$7.10M | — |
| 2026-05-31 | US$86.61M | -US$11.40M | — |
| 2026-02-28 | US$78.42M | -US$8.08M | — |
| 2025-11-30 | US$79.43M | -US$6.35M | — |
| 2025-08-31 | US$75.71M | -US$10.90M | — |
| 2025-05-31 | US$80.16M | -US$6.05M | — |
| 2025-02-28 | US$72.00M | -US$4.41M | — |
| 2024-11-30 | US$72.84M | -US$10.74M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.